Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RECOMBINANT SOLUBLE CD4' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 67 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Miller, MD; Hazuda, DJ
      New antiretroviral agents: looking beyond protease and reverse transcriptase

      CURRENT OPINION IN MICROBIOLOGY
    2. Si, ZH; Cayabyab, M; Sodroski, J
      Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys

      JOURNAL OF VIROLOGY
    3. Kolchinsky, P; Kiprilov, E; Sodroski, J
      Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants

      JOURNAL OF VIROLOGY
    4. Verrier, F; Nadas, A; Gorny, MK; Zolla-Pazner, S
      Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6

      JOURNAL OF VIROLOGY
    5. Clapham, PR; McKnight, A
      HIV-1 receptors and cell tropism

      BRITISH MEDICAL BULLETIN
    6. Rusconi, S; Merill, DP; Catamancio, SL; Citterio, P; Bulgheroni, E; Croce, F; Chou, TC; Yang, OO; Herrmann, SH; Galli, M; Hirsch, MS
      In vitro inhibition of HIV-1 by Met-SDF-1 beta alone or in combination with antiretroviral drugs

      ANTIVIRAL THERAPY
    7. Esser, U; Speck, RF; Deen, KC; Atchison, RE; Sweet, R; Goldsmith, MA
      Molecular function of the CD4 D1 domain in coreceptor-mediated entry by HIV type 1

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    8. Duzgunes, N; Pretzer, E; Simoes, S; Slepushkin, V; Konopka, K; Flasher, D; de Lima, MCP
      Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells

      MOLECULAR MEMBRANE BIOLOGY
    9. Shinya, E; Dervillez, X; Edwards-Levy, F; Duret, V; Brisson, E; Ylisastigui, L; Levy, MC; Cohen, JHM; Klatzmann, D
      In-vivo delivery of therapeutic proteins by genetically-modified cells: comparison of organoids and human serum albumin alginate-coated beads

      BIOMEDICINE & PHARMACOTHERAPY
    10. KILBY JM; HOPKINS S; VENETTA TM; DIMASSIMO B; CLOUD GA; LEE JY; ALLDREDGE L; HUNTER E; LAMBERT D; BOLOGNESI D; MATHEWS T; JOHNSON MR; NOWAK MA; SHAW GM; SAAG MS
      POTENT SUPPRESSION OF HIV-1 REPLICATION IN HUMANS BY T-20, A PEPTIDE INHIBITOR OF GP41-MEDIATED VIRUS ENTRY

      Nature medicine
    11. BUNNELL BA; MORGAN RA
      GENE-THERAPY FOR INFECTIOUS-DISEASES

      Clinical microbiology reviews
    12. NAITO T; TAKEDAHIROKAWA N; KANEKO H; SEKIGAWA I; MATSUMOTO T; HASHIMOTO H; KANEKO Y
      ROLE OF CURDLAN SULFATE IN THE PRODUCTION OF BETA-CHEMOKINES AND INTERLEUKIN-16

      Medical microbiology and immunology
    13. DAVARO RE; BOTTARO E
      CHEMOKINES AND THEIR RECEPTORS - 2 NEW AC TORS IN THE PHYSIOPATHOLOGYOF HIV-INFECTION

      Medicina
    14. STENT G; CROWE SM
      EFFECTS OF HIV-1 ON THE SURFACE EXPRESSION OF LFA-1 ON CULTURED MONOCYTES

      Journal of acquired immune deficiency syndromes and human retrovirology
    15. GUAY LA; SIERRAMADERO JG; FINEGAN CK; RICH EA
      MEDIATION OF ENTRY OF HUMAN IMMUNODEFICIENCY VIRUS-1 INTO ALVEOLAR MACROPHAGES BY CD4 WITHOUT FACILITATION BY SURFACTANT-ASSOCIATED PROTEIN-A

      American journal of respiratory cell and molecular biology
    16. GROENINK M; SWART PJ; BROERSEN S; KUIPERS M; MEIJER DKF; SCHUITEMAKER H
      POTENT INHIBITION OF REPLICATION OF PRIMARY HIV TYPE-1 ISOLATES IN PERIPHERAL-BLOOD LYMPHOCYTES BY NEGATIVELY CHARGED HUMAN SERUM ALBUMINS

      AIDS research and human retroviruses
    17. TAKEDAHIROKAWA N; NEOH LP; AKIMOTO H; KANEKO H; HISHIKAWA T; SEKIGAWA I; HASHIMOTO H; HIROSE S; MURAKAMI T; YAMAMOTO N; MIMURA T; KANEKO Y
      ROLE OF CURDLAN SULFATE IN THE BINDING OF HIV-1 GP120 TO CD4 MOLECULES AND THE PRODUCTION OF GP120-MEDIATED TNF-ALPHA

      Microbiology and immunology
    18. KANEKO H; NEOH LP; TAKEDA N; AKIMOTO H; HISHIKAWA T; HASHIMOTO H; HIROSE S; KARAKI S; TAKIGUCHI M; NAKAUCHI H; KANEKO Y; YAMAMOTO N; SEKIGAWA I
      HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 ENVELOPE GLYCOPROTEIN BINDS TO CD8 AS WELL AS TO CD4 MOLECULES ON HUMAN T-CELLS

      Journal of virology
    19. MORI T; SHOEMAKER RH; MCMAHON JB; GULAKOWSKI RJ; GUSTAFSON KR; BOYD MR
      CONSTRUCTION AND ENHANCED CYTOTOXICITY OF A [CYANOVIRIN-N]-[PSEUDOMONAS EXOTOXIN] CONJUGATE AGAINST HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CELLS

      Biochemical and biophysical research communications
    20. SINCLAIR JP; SHEARER WT
      CURRENT STATUS OF CD4-BASED THERAPIES FOR PROPHYLAXIS AND TREATMENT OF HIV-INFECTION

      Biodrugs
    21. CLEMENT JM; JEHANNO M; POPESCU O; SAURIN W; HOFNUNG M
      EXPRESSION AND BIOLOGICAL-ACTIVITY OF GENETIC FUSIONS BETWEEN MALE, THE MALTOSE-BINDING PROTEIN FROM ESCHERICHIA-COLI AND PORTIONS OF CD4, THE T-CELL RECEPTOR OF THE AIDS VIRUS

      Protein expression and purification
    22. PINCUS SH; WEHRLY K; COLE R; FANG H; LEWIS GK; MCCLURE J; CONLEY AJ; WAHREN B; POSNER MR; NOTKINS AL; TILLEY SA; PINTER A; EIDEN L; TEINTZE M; DORWARD D; TOLSTIKOV VV
      IN-VITRO EFFECTS OF ANTI-HIV IMMUNOTOXINS DIRECTED AGAINST MULTIPLE EPITOPES ON HIV TYPE-1 ENVELOPE GLYCOPROTEIN-160

      AIDS research and human retroviruses
    23. POIGNARD P; KLASSE PJ; SATTENTAU QJ
      ANTIBODY NEUTRALIZATION OF HIV-1

      Immunology today
    24. SCHNEIDER J; WEIS R; MANNER C; KARY B; WERNER A; SEUBERT BJ; RIEDE UN
      INHIBITION OF HIV-1 IN CELL-CULTURE BY SYNTHETIC HUMATE ANALOGS DERIVED FROM HYDROQUINONE - MECHANISM OF INHIBITION

      Virology
    25. THRELKELD SC; HIRSCH MS
      ANTIRETROVIRAL THERAPY

      The Medical clinics of North America
    26. OBRIEN WA; SUMNERSMITH M; MAO SH; SADEGHI S; ZHAO JQ; CHEN IY
      ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY OF AN OLIGOCATIONICCOMPOUND MEDIATED VIA GP120 V3 INTERACTIONS

      Journal of virology
    27. BERKOWER I; MOSTOWSKI H; BULL TE; MURPHY D
      CD4-IGG BINDING THRESHOLD FOR INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      The Journal of infectious diseases
    28. TOSI PF; SCHWARTZ D; SHARMA U; MOUNEIMNE Y; HANNIG J; LI GR; MCKINLEY G; GRIECO M; FLEXNER CW; LAZARTE J; NORSE D; NICOLAU C; VOLSKY DJ
      HUMAN ERYTHROCYTES BEARING ELECTROINSERTED CD4 NEUTRALIZE INFECTION IN-VITRO BY PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I

      Blood
    29. HOLLINGER FB; MOUNEIMNE Y; LAHART C; TOSI PF; DIMITROV D; NICOLAU C
      LIFE-SPAN OF CIRCULATING MEMBRANE CD4 INSERTED INTO THE PLASMA-MEMBRANES OF AUTOLOGOUS RED-BLOOD-CELLS OF HIV-INFECTED SUBJECTS

      Journal of acquired immune deficiency syndromes and human retrovirology
    30. SCHACKER T; COLLIER AC; COOMBS R; UNADKAT JD; FOX I; ALAM J; WANG JP; EGGERT E; COREY L
      PHASE-I STUDY OF HIGH-DOSE, INTRAVENOUS RSCD4 IN SUBJECTS WITH ADVANCED HIV-1 INFECTION

      Journal of acquired immune deficiency syndromes and human retrovirology
    31. MENG TC; FISCHL MA; CHEESEMAN SH; SPECTOR SA; RESNICK L; BOOTA A; PETRAKIS T; WRIGHT B; RICHMAN DD
      COMBINATION THERAPY WITH RECOMBINANT HUMAN SOLUBLE CD4-IMMUNOGLOBULIN-G AND ZIDOVUDINE IN PATIENTS WITH HIV-INFECTION - A PHASE-I STUDY

      Journal of acquired immune deficiency syndromes and human retrovirology
    32. COLLIER AC; COOMBS RW; KATZENSTEIN D; HOLODNIY M; GIBSON J; MORDENTI J; IZU AE; DULIEGE AM; AMMANN AJ; MERIGAN T; COREY L
      SAFETY, PHARMACOKINETICS, AND ANTIVIRAL RESPONSE OF CD4-IMMUNOGLOBULIN-G BY INTRAVENOUS BOLUS IN AIDS AND AIDS-RELATED COMPLEX

      Journal of acquired immune deficiency syndromes and human retrovirology
    33. SHIMIZU NS; HANDA A; SHIMIZU NG; IKEDA R; UCHIYAMA T; ACHIWA K; HOSHINO H
      INHIBITION OF INFECTION OF T-CELLS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY DIDEOXYNUCLEOSIDES CONJUGATED WITH OLIGOPEPTIDES

      Antiviral chemistry & chemotherapy
    34. ALLAWAY GP; DAVISBRUNO KL; BEAUDRY GA; GARCIA EB; WONG EL; RYDER AM; HASEL KW; GAUDUIN MC; KOUP RA; MCDOUGAL JS; MADDON PJ
      EXPRESSION AND CHARACTERIZATION OF CD4-IGG(2), A NOVEL HETEROTETRAMERTHAT NEUTRALIZES PRIMARY HIV TYPE-1 ISOLATES

      AIDS research and human retroviruses
    35. WYATT R; MOORE J; ACCOLA M; DESJARDIN E; ROBINSON J; SODROSKI J
      INVOLVEMENT OF THE V1 V2 VARIABLE LOOP STRUCTURE IN THE EXPOSURE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 EPITOPES INDUCED BY RECEPTOR-BINDING/

      Journal of virology
    36. CHOE HR; SODROSKI J
      ADAPTATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO CELLS EXPRESSINGA BINDING-DEFICIENT CD4 MUTANT (LYSINE-46 TO ASPARTIC-ACID)

      Journal of virology
    37. WRIN T; LOH TP; VENNARI JC; SCHUITEMAKER H; NUNBERG JH
      ADAPTATION TO PERSISTENT GROWTH IN THE H9 CELL-LINE RENDERS A PRIMARYISOLATE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SENSITIVE TO NEUTRALIZATION BY VACCINE SERA

      Journal of virology
    38. FREED EO; MARTIN MA
      THE ROLE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS IN VIRUS-INFECTION

      The Journal of biological chemistry
    39. LEVER AML
      GENE-THERAPY FOR HIV-INFECTION

      British Medical Bulletin
    40. CAVACINI LA; POWER J; EMES CL; MACE K; TREACY G; POSNER MR
      PLASMA PHARMACOKINETICS AND BIOLOGICAL-ACTIVITY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZING HUMAN MONOCLONAL-ANTIBODY, F105, IN CYNOMOLGUS MONKEYS

      Journal of immunotherapy with emphasis on tumor immunology
    41. PIZZO PA; WILFERT C
      ANTIRETROVIRAL THERAPY FOR INFECTION DUE TO HUMAN-IMMUNODEFICIENCY-VIRUS IN CHILDREN

      Clinical infectious diseases
    42. CHAMOW SM; KOGAN TP; VENUTI M; GADEK T; HARRIS RJ; PEERS DH; MORDENTI J; SHAK S; ASHKENAZI A
      MODIFICATION OF CD4 IMMUNOADHESIN WITH MONOMETHOXYPOLY(ETHYLENE GLYCOL) ALDEHYDE VIA REDUCTIVE ALKYLATION

      Bioconjugate chemistry
    43. DROPULIC B; JEANG KT
      GENE-THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - GENETIC ANTIVIRAL STRATEGIES AND TARGETS FOR INTERVENTION

      Human gene therapy
    44. YU M; POESCHLA E; WONGSTAAL F
      PROGRESS TOWARDS GENE-THERAPY FOR HIV-INFECTION

      Gene therapy
    45. OBRIEN WA
      HIV-1 ENTRY AND REVERSE TRANSCRIPTION IN MACROPHAGES

      Journal of leukocyte biology
    46. MEYLAN PRA; KORNBLUTH RS; ZBINDEN I; RICHMAN DD
      INFLUENCE OF HOST-CELL TYPE AND V3 LOOP OF THE SURFACE GLYCOPROTEIN ON SUSCEPTIBILITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO POLYANION COMPOUNDS

      Antimicrobial agents and chemotherapy
    47. SPOUGE JL
      VIRAL MULTIPLICITY OF ATTACHMENT AND ITS IMPLICATIONS FOR HUMAN-IMMUNODEFICIENCY-VIRUS THERAPIES

      Journal of virology
    48. RAMACHANDRAN RV; KATZENSTEIN DA; WOOD R; BATTS DH; MERIGAN TC
      FAILURE OF SHORT-TERM CD4-PE40 INFUSIONS TO REDUCE VIRUS LOAD IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS

      The Journal of infectious diseases
    49. MALVOISIN E; WILD F
      ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE PROTEIN-INTERACTION WITH THE CD4 HOST-CELL RECEPTOR

      Journal of General Virology
    50. BERGAMINI A; PERNO CF; DINI L; CAPOZZI M; PESCE CD; VENTURA L; CAPPANNOLI L; FALASCA L; MILANESE G; CALIO R; ROCCHI G
      MACROPHAGE-COLONY-STIMULATING FACTOR ENHANCES THE SUSCEPTIBILITY OF MACROPHAGES TO INFECTION BY HUMAN-IMMUNODEFICIENCY-VIRUS AND REDUCES THE ACTIVITY OF COMPOUNDS THAT INHIBIT VIRUS BINDING

      Blood
    51. ACOSTA EP; FLETCHER CV
      AGENTS FOR TREATING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      American journal of hospital pharmacy
    52. FISH DN
      PROPHYLAXIS OF HIV-INFECTION FOLLOWING OCCUPATIONAL EXPOSURE

      The Annals of pharmacotherapy
    53. WEBER J
      THE MOLECULAR-BASIS OF ANTIRETROVIRAL THERAPY

      Journal of antimicrobial chemotherapy
    54. LANGNER KD; NIEDRIG M; FULTZ P; ANDERSON D; REINER G; REPKE H; GELDERBLOM H; SEED B; HILFENHAUS J; ZETTLMEISSL G
      ANTIVIRAL EFFECTS OF DIFFERENT CD4-IMMUNOGLOBULIN CONSTRUCTS AGAINST HIV-1 AND SIV - IMMUNOLOGICAL CHARACTERIZATION, PHARMACOKINETIC DATA AND INVIVO EXPERIMENTS

      Archives of virology
    55. FLETCHER CV
      CURRENT PERSPECTIVES ON ANTIRETROVIRAL THERAPY

      Pharmacotherapy
    56. MOHAN P
      PROBLEMS AND PERSPECTIVES IN THE DESIGN OF ANTI-HIV-1 AGENTS

      Drug development research
    57. KOUP RA; BREWSTER F; GROB P; SULLIVAN JL
      NEVIRAPINE SYNERGISTICALLY INHIBITS HIV-1 REPLICATION IN COMBINATION WITH ZIDOVUDINE, INTERFERON OR CD4 IMMUNOADHESIN

      AIDS
    58. FLETCHER CV; ACOSTA EP
      ADVANCES IN PHARMACOTHERAPY - TREATMENT OF HIV-INFECTION

      Journal of clinical pharmacy and therapeutics
    59. JOHNSTON MI; HOTH DF
      PRESENT STATUS AND FUTURE-PROSPECTS FOR HIV THERAPIES

      Science
    60. HIRSCH MS; DAQUILA RT
      THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      The New England journal of medicine
    61. LANZA P; BILLETTA R; ANTONENKO S; ZANETTI M
      ACTIVE IMMUNITY AGAINST THE CD4 RECEPTOR BY USING AN ANTIBODY ANTIGENIZED WITH RESIDUES 41-55 OF THE 1ST EXTRACELLULAR DOMAIN

      Proceedings of the National Academy of Sciences of the United Statesof America
    62. WYATT R; SULLIVAN N; THALI M; REPKE H; HO D; ROBINSON J; POSNER M; SODROSKI J
      FUNCTIONAL AND IMMUNOLOGICAL CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS CONTAINING DELETIONS OF THE MAJOR VARIABLE REGIONS

      Journal of virology
    63. FU YK; HART TK; JONAK ZL; BUGELSKI PJ
      PHYSICOCHEMICAL DISSOCIATION OF CD4-MEDIATED SYNCYTIUM FORMATION AND SHEDDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120

      Journal of virology
    64. SANDSTROM E; OBERG B
      ANTIVIRAL THERAPY IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTIONS - CURRENT STATUS .2.

      Drugs
    65. JEFFRIES D
      DRUG-THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Chemistry and Industry
    66. NICOLAU C; MOUNEIMNE Y; TOSI PF
      ELECTROINSERTION OF PROTEINS IN THE PLASMA-MEMBRANE OF RED-BLOOD-CELLS

      Analytical biochemistry
    67. HARRISON SC; WANG J; YAN Y; GARRETT T; LIU J; MOEBIUS U; REINHERZ E
      STRUCTURE AND INTERACTIONS OF CD4

      Cold Spring Harbor Symposia on Quantitative Biology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 20:18:19